Protein kinase C and other diacylglycerol effectors in cancer
The DOI matches its Crossref record; 191 of the 191 references it cites were found in a registry or an index.
Abstract
Almost three decades after the discovery of protein kinase C (PKC), we still have only a partial understanding of how this family of serine/threonine kinases is involved in tumour promotion. PKC isozymes - effectors of diacylglycerol (DAG) and the main targets of phorbol-ester tumour promoters - have important roles in cell-cycle regulation, cellular survival, malignant transformation and apoptosis. How do PKC isozymes regulate these diverse cellular processes and what are their contributions to carcinogenesis? Moreover, what is the contribution of all phorbol-ester effectors, which include PKCs and small G-protein regulators? We now face the challenge of dissecting the relative contribution of each DAG signal to cancer progression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IP3 triggers calcium release from intracellular stores, while DAG activates protein kinase C (PKC) and other effector proteins, ultimately influencing microglial processes such as migration, phagocytosis, cytokine secretion, and metabolic responses. 13 , 16 , 17”
From Alzheimer's disease–associated PLCG2 variants alter microglial state and function in human induced pluripotent stem cell–derived microglia‐like cells (2025) · cites this paper as [17]
In the citing paper
“and DAG leading to activation of protein kinase C (PKC) isozymes, the NLRP3 inflammasome [31, 34], as well as other proteins [77].”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [77]
In the citing paper
“Conversely, phorbol esters, the naturally occurring activating ligands of PKC, showed tumor‐promoting functions, suggesting that PKC could be an oncogene [111, 120, 121].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [121]
Citations
Cites
Castagna, M., Takai, Y., Kaibuchi, K., Sano, K., Kikkawa, U., & Nishizuka, Y. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34459-4 · Cited by 4,725 · cited 3×
“Chimaerins (α2, β2) Rac-GAPC1SH2 PKDs (1, 2, 3) C1A C1B Protein kinasePH nPKCs (δ, ε, η, θ) Protein kinaseC2 C1A C1B ApcMin/+mouse A mouse strain harbouring a nonsense mutation at codon 850 in one allele of the Apc (adenomatous polyposis coli) gene.”
BackgroundKishimoto, A., Takai, Y., Mori, T., Kikkawa, U., & Nishizuka, Y. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85886-6 · Cited by 1,303
Protein kinase C as a possible receptor protein of tumor‐promoting phorbol esters
Kikkawa, U., Takai, Y., Tanaka, Y., Miyake, R., & Nishizuka, Y. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44245-1 · Cited by 881 · cited 2×
“Chimaerins (α2, β2) Rac-GAPC1SH2 PKDs (1, 2, 3) C1A C1B Protein kinasePH nPKCs (δ, ε, η, θ) Protein kinaseC2 C1A C1B ApcMin/+mouse A mouse strain harbouring a nonsense mutation at codon 850 in one allele of the Apc (adenomatous polyposis coli) gene.”
Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm
NEWTON, A. C. (2003) · Biochemical Journal · doi:10.1042/bj20021626 · Cited by 798
Takai, Y., Kishimoto, A., Kikkawa, U., Mori, T., & Nishizuka, Y. (1979) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(79)91197-5 · Cited by 731 · cited 1×
“Nishizuka and colleagues found that PKC could be activated by the lipid diacylglycerol (DAG) in the presence of phosphatidylserine as a cofacto”
BackgroundRasGRP, a Ras Guanyl Nucleotide- Releasing Protein with Calcium- and Diacylglycerol-Binding Motifs
Ebinu, J. O., Bottorff, D. A., Chan, E. Y. W., Stang, S. L., Dunn, R. J., & Stone, J. C. (1998) · Science · doi:10.1126/science.280.5366.1082 · Cited by 689
Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells.
Emoto, Y., Manome, Y., Meinhardt, G., Kisaki, H., Kharbanda, S., Robertson, M., Ghayur, T., Wong, W. W., Kamen, R., & Weichselbaum, R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00305.x · Cited by 670
Multiple pathways control protein kinase C phosphorylation
Parekh, D. B., Ziegler, W., & Parker, P. J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.4.496 · Cited by 601 · cited 1×
“The mechanisms involved in PKC activation have been extensively studie”
BackgroundTakahashi, T., Ueno, H., & Shibuya, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202527 · Cited by 571
Xia, P., Aiello, L. P., Ishii, H., Jiang, Z. Y., Park, D. J., Robinson, G. S., Takagi, H., Newsome, W. P., Jirousek, M. R., & King, G. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119006 · Cited by 566 · cited 1×
“Several PKC isoforms, including PKCα, β and e, are activated in response to VEGF receptor activation, and PKC has been implicated as an important mediator of VEGF-induced proliferation of endothelial cell”
Background
Research works printed but not linked: 1
- Wu, E. X. et al. PKCβ: a rational therapeutic target in diffuse large B-cell lymphoma. Blood 100, 202A–202A (2002).
Cited by
Items 201–300 of 1,000
Yin, H., Wang, M., Li, B., Yang, Z., Zhou, Y., & Ai, S. (2014) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2014.07.016 · Cited by 59
Protein kinase C mechanisms that contribute to cardiac remodelling
Newton, A. C., Antal, C. E., & Steinberg, S. F. (2016) · Clinical Science · doi:10.1042/cs20160036 · Cited by 60
Acid β-Glucosidase 1 Counteracts p38δ-dependent Induction of Interleukin-6
Kitatani, K., Sheldon, K. L., Anelli, V., Jenkins, R. W., Sun, Y., Grabowski, G. A., Obeid, L. M., & Hannun, Y. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809500200 · Cited by 65
Sarveswaran, S., Thamilselvan, V., Brodie, C., & Ghosh, J. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.07.015 · Cited by 62
“In the first step, PKCε gets phosphorylated at a threonine residue at the activation loop by phospholipid-dependent kinase1 (PDK1) which triggers autophosphorylation on a threonine residue in the turn motif and serine residues in the hydrophobic motif [37].”
BackgroundMolecular Modeling, Total Synthesis, and Biological Evaluations of C9‐Deoxy Bryostatin 1
Keck, G. E., Poudel, Y. B., Rudra, A., Stephens, J. C., Kedei, N., Lewin, N. E., Peach, M. L., & Blumberg, P. M. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201001200 · Cited by 58
Protein Kinase C Quality Control by Phosphatase PHLPP1 Unveils Loss-of-Function Mechanism in Cancer
Baffi, T. R., Van, A. N., Zhao, W., Mills, G. B., & Newton, A. C. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.02.018 · Cited by 58
“PKC familymembers transducemyriad signals downstream of phospholipid hydrolysis to regulate diverse cellular functions such as proliferation, apoptosis, migration, and differentiation (Griner and Kazanietz, 2007; Newton, 2018).”
BackgroundKveiborg, M., Instrell, R., Rowlands, C. T., Howell, M. T., & Parker, P. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017168 · Cited by 57
“including proliferation, survival, migration and invasion [26].”
Phospholipase D inhibitors reduce human prostate cancer cell proliferation and colony formation
Noble, A. R., Maitland, N. J., Berney, D. M., & Rumsby, M. G. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.391 · Cited by 57
“This is because stromal growth factors such as EGF and IGF can stimulate PKC (Griner and Kazanietz, 2007; Lemmon and Schlessinger, 2010; Dowling and Kiely, 2015) thereby activating PLD1 and increasing PtdOH formation and mTOR signalling (Foster, 2009; Zhou and Huang, 2011).”
BackgroundInfluentialTotal Synthesis of Bryostatin 8 Using an Organosilane‐Based Strategy
Zhang, Y., Guo, Q., Sun, X., Lu, J., Cao, Y., Pu, Q., Chu, Z., Gao, L., & Song, Z. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201711452 · Cited by 57
Aziz, M. H., Manoharan, H. T., Sand, J. M., & Verma, A. K. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20356 · Cited by 62
“Stat3 is constitutively activated in a wide variety of human cancers [reviewed in References [9] and [10]].”
BackgroundZabkiewicz, J., Pearn, L., Hills, R. K., Morgan, G., Tonks, A., Burnett, A. K., & Darley, R. L. (2013) · Haematologica · doi:10.3324/haematol.2013.096487 · Cited by 61
“Many of these kinases have been shown to be constitutively active in tumor tissue including: AKT,(4) S6K,(5) SGK,(6) RSK(7) and PKC isoforms.(8) Genetic knockout studies have demonstrated that PDK1 is essential for the activation of these kinases.”
BackgroundYang, C., Klein, E. A., Assoian, R. K., & Kazanietz, M. G. (2008) · Biochemical Journal · doi:10.1042/bj20070781 · Cited by 63
Self-citationEnzastaurin: A lesson in drug development
Bourhill, T., Narendran, A., & Johnston, R. N. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.02.003 · Cited by 55
Matono, R., Miyano, K., Kiyohara, T., & Sumimoto, H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.581785 · Cited by 56
“By contrast, the endogenous PMA analog diacylglycerol acts transiently because of its fast metabolism (41).”
BackgroundNon-hematopoietic expression of IDO is integrally required for inflammatory tumor promotion
Muller, A. J., DuHadaway, J. B., Chang, M. Y., Ramalingam, A., Sutanto‐Ward, E., Boulden, J., Soler, A. P., Mandik‐Nayak, L., Gilmour, S. K., & Prendergast, G. C. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0891-4 · Cited by 57
“TPA acts as a molecular mimic of diacylglycerol (DAG), activating protein kinase C (PKC) isoenzymes as well as other DAG-binding proteins carrying the C1 domain [ 43 ].”
PKCδ activation mediates angiogenesis via NADPH oxidase activity in PC‐3 prostate cancer cells
Kim, J., Koyanagi, T., & Mochly‐Rosen, D. (2010) · The Prostate · doi:10.1002/pros.21310 · Cited by 55
“As such, PKCd was generally found to be pro-apoptotic [21,27,33].”
BackgroundEsnault, C., Gualdrini, F., Horswell, S., Kelly, G., Stewart, A., East, P., Matthews, N., & Treisman, R. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.02.005 · Cited by 57
“Stimulation with 12-O-tetradecanoyl phorbol-13-acetate (TPA), which activates ERK, but not Rho-actin signaling (Griner and Kazanietz, 2007), activates almost 3,500 genes, including more than 700 direct SRF genomic targets, in a largely TCF-dependent fashion (Gualdrini et al.”
BackgroundRoy, J., Dibaeinia, P., Fan, T. M., Sinha, S., & Das, A. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m088559 · Cited by 60
“DG levels in cancer cells has been shown to be dysregulated, signaling through the protein kinase C (PKC) pathway (34).”
BackgroundUveal melanoma: progress in molecular biology and therapeutics
Li, Y., Shi, J., Yang, J., Ge, S., Zhang, J., Jia, R., & Fan, X. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920965852 · Cited by 62
Awadelkarim, K. D., Callens, C., Rossé, C., Susini, A., Vacher, S., Rouleau, É., Lidereau, R., & Bièche, I. (2012) · International Journal of Cancer · doi:10.1002/ijc.27600 · Cited by 54
“Protein kinase C (PKC) family members are key cell-signal transducers regulating several cell functions such as proliferation, differentiation, apoptosis, migration and angiogenesis.(1) The 11 serine-threonine kinases composing the PKC family have been classified according to their structural and activational properti…”
BackgroundResultInfluentialPKC-mediated phosphorylation regulates c-FLIP ubiquitylation and stability
Kaunisto, A., Kochin, V., Asaoka, T., Mikhailov, A., Poukkula, M., Meinander, A., & Eriksson, J. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.35 · Cited by 58
Caino, M. C., López‐Haber, C., Kissil, J. L., & Kazanietz, M. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031714 · Cited by 57
“altered in human lung cancer [4], although a causal relationship”
BackgroundSelf-citationOptimal control nodes in disease-perturbed networks as targets for combination therapy
Hu, Y., Chen, C., Ding, Y., Xiao, W., Wang, B., Gao, L., & Tan, K. (2019) · Nature Communications · doi:10.1038/s41467-019-10215-y · Cited by 57
Targeting TRPC6 channels in oesophageal carcinoma growth
Ding, X., He, Z., Shi, Y., Wang, Q., & Wang, Y. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728221003733602 · Cited by 55
“Ca effectors CaM Modulates cyclin E/Cdk2 activity [111] Regulates Rb phosphorylation and is required for DNA synthesis [2] S100 S100A4 sequesters and disables p53 and abrogates G1/S checkpoint control [112] S100B promotes p53 nuclear translocation and G1 checkpoint control [113] Ca-sensitive enzymes CaM kinase II Is r…”
BackgroundThe therapeutic role of targeting protein kinase C in solid and hematologic malignancies
Podar, K., Raab, M. S., Chauhan, D., & Anderson, K. C. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.10.1693 · Cited by 56
“In addition to DAG-induced effects, transphosphorylation and autophosphorylation are also required for PKC stabilization and activation, and may even allow for DAG-independent PKC activation [7] .”
BackgroundInfluentialCentrosomal PKCβII and Pericentrin Are Critical for Human Prostate Cancer Growth and Angiogenesis
Kim, J., Choi, Y.-L., Vallentin, A., Hunrichs, B. S., Hellerstein, M. K., Peehl, D. M., & Mochly-Rosen, D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6195 · Cited by 54
Ivanov, A. I., Samarin, S., Bachar, M., Parkos, C. A., & Nusrat, A. (2009) · BMC Cell Biology · doi:10.1186/1471-2121-10-36 · Cited by 54
Kikumori, M., Yanagita, R. C., Tokuda, H., Suzuki, N., Nagai, H., Suenaga, K., & Irie, K. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300566h · Cited by 55
Understanding relaxin signalling at the cellular level
Valkovic, A. L., Bathgate, R. A. D., Samuel, C. S., & Kočan, M. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.12.017 · Cited by 54
Transgenic overexpression of PKCε in the mouse prostate induces preneoplastic lesions
Benavides, F. J., Blando, J. M., Pérez, C. J., Garg, R., Conti, C. J., DiGiovanni, J., & Kazanietz, M. G. (2011) · Cell Cycle · doi:10.4161/cc.10.2.14469 · Cited by 53
“Members of the classical PKCs (cPKCs α, β and γ) and novel PKCs (nPKCs δ, ε, η and θ) are main cellular targets for the phorbol ester tumor promoters and the second messenger diacylglycerol (DAG) generated in response to the activation of growth factor receptors.(1,2) Studies in cancer cell models have established ess…”
BackgroundSelf-citationThe Scaffold MyD88 Acts to Couple Protein Kinase Cϵ to Toll-like Receptors
Faisal, A., Saurin, A. T., Gregory, B., Foxwell, B. M. J., & Parker, P. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710330200 · Cited by 52
Xiao, L., Eto, M., & Kazanietz, M. G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.007971 · Cited by 52
Self-citationSingh, A., & Prasad, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019266 · Cited by 51
Keck, G. E., Li, W., Kraft, M. B., Kedei, N., Lewin, N. E., & Blumberg, P. M. (2009) · Organic Letters · doi:10.1021/ol900585t · Cited by 52
Pejchar, P., Potocký, M., Novotná, Z., Veselková, Š., Kocourková, D., Valentová, O., Schwarzerová, K., & Martinec, J. (2010) · New Phytologist · doi:10.1111/j.1469-8137.2010.03349.x · Cited by 52
“Protein kinase C (PKC) is the principal target of DAG regulation in animal cells (Griner & Kazanietz, 2007).”
BackgroundZheng, X. T., Hu, W., Wang, H., Yang, H., Zhou, W., & Li, C. M. (2011) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2011.05.007 · Cited by 53
Das, J., Pany, S., Panchal, S., Majhi, A., & Rahman, G. M. S. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.09.011 · Cited by 52
Differential effect of molecular size HA in mouse chondrocytes stimulated with PMA
Campo, G. M., Avenoso, A., Campo, S., D’Ascola, A., Traina, P., & Calatroni, A. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.07.003 · Cited by 56
“[29] PKC is implicated in the invasion of cancer cells and its activation state regulates a number of elements potentially implicated in HA–CD44 interaction [32].”
BackgroundFunctionally Diverse MicroRNA Effector Complexes Are Regulated by Extracellular Signaling
Wu, P., Isaji, M., & Carthew, R. W. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.08.023 · Cited by 60
“The protein kinase C (PKC) family is an extensively studied group of kinases that integrates multiple lipid- and insulin-activated signals from serum (Griner and Kazanietz, 2007; Newton, 1995).”
Akbulut, S., Reddi, A. L., Aggarwal, P., Ambardekar, C., Canciani, B., Kim, M. K. H., Hix, L. M., Vilimas, T., Mason, J. M., Basson, M. A., et al. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-02-0123 · Cited by 58
“Increased PLC activity leads to the recruitment of protein kinase C molecules, including PKC , to the plasma membrane (Griner and Kazanietz, 2007), and DAG-mediated allosteric changes in PKC cooperate with the action of the serine-threonine kinase PDK1 to phosphorylate and activate the kinase (Le Good et al.”
Locally Generated Methylseleninic Acid Induces Specific Inactivation of Protein Kinase C Isoenzymes
Gundimeda, U., Schiffman, J. E., Chhabra, D., Wong, J., Wu, A., & Gopalakrishna, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807007200 · Cited by 52
Fast Antioxidation Kinetics of Glutathione Intracellularly Monitored by a Dual‐Wire Nanosensor
Jiao, Y., Kang, Y., Wen, M., Wu, H., Zhang, X., & Huang, W. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202313612 · Cited by 53
Litherland, G. J., Elias, M. S., Wang, H., Macdonald, C. D., Catterall, J., Barter, M. J., Farren, M. J., Jefferson, M. A., & Rowan, A. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.120121 · Cited by 55
Spatiotemporal Dynamics of Phosphorylation in Lipid Second Messenger Signaling
Antal, C. E., & Newton, A. C. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r113.029819 · Cited by 52
Chao, M., Chen, T.-H., Huang, H.-L., Chang, Y.-W., HuangFu, W., Lee, Y., Teng, C., & Pan, S. (2017) · Scientific Reports · doi:10.1038/srep46134 · Cited by 56
The Caspase-3/PKCδ/Akt/VEGF-A Signaling Pathway Mediates Tumor Repopulation during Radiotherapy
Cheng, J. Q., He, S., Wang, M., Zhou, L., Zhang, Z., Xiao, F., Yu, Y., Ma, J., Dai, C., Zhang, S., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3001 · Cited by 56
“The catalytic fragment of PKCd liberated by caspase-3 cleavage became constitutively activated and translocated into the nucleus, where it phosphorylated several proapoptotic proteins, including p53, p73b, and Rad9 (24, 25).”
BackgroundAtypical protein kinase C in cell motility
Xiao, H., & Liu, M. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1192-1 · Cited by 54
“The various PKCs are grouped into three subfamilies: (1) classic or conventional PKCs (a, bI, bII and c); (2) novel PKCs (d, e, g and h); and (3) atypical PKCs (f and k/i) [13].”
BackgroundLess stress, more success? Oncological implications of surgery-induced oxidative stress
O’Leary, D., Wang, J. H., Cotter, T. G., & Redmond, H. P. (2011) · Gut · doi:10.1136/gutjnl-2011-300948 · Cited by 55
Xiao, H., Bai, X.-H., Kapùs, A., Lu, W.-Y., Mak, A. S., & Liu, M. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00382-10 · Cited by 50
“ical signal transducers participating in many agonist-induced signaling cascades (13) as well as in mechanotransduction in lung cells (24).”
BackgroundHsu, Y., & Kuo, P. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080219 · Cited by 50
“cellular physiological functions, such as growth, cell death, and differentiation.((17,18)) The novel PKC isoform, PKC”
BackgroundProtein kinase C signaling “in” and “to” the nucleus: Master kinases in transcriptional regulation
Kazanietz, M. G., & Cooke, M. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.105692 · Cited by 51
Self-citationMüller, K. M., Tveteraas, I. H., Aasrum, M., Ødegård, J., Dawood, M., Dajani, O. F., Christoffersen, T., & Sandnes, D. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-421 · Cited by 49
“Stimulation of these receptors leads to activation of phospholipase Cb (PLCb) and thereby of protein kinase C (PKC), which may be involved in tumorigenesis [7].”
BackgroundChai, D., Wang, B., Shen, L., Pu, J., Zhang, X.-K., & He, B. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.12.022 · Cited by 49
“Protein kinase C (PKC) isozymes, a family of serine/threonine kinases and downstream targets of diacylglycerol and phorbol ester tumor promoters [5], are also involved in the regulation of endothelial NADPH oxidase [6].”
BackgroundMagnani, N., Dada, L. A., Queisser, M. A., Brazee, P. L., Welch, L. C., Anekalla, K. R., Zhou, G., Vagin, O., Misharin, A. V., Budinger, G. R. S., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1713563114 · Cited by 51
“and is considered the key event in stabilizing PKCζ in the active conformation at the plasma membrane (37).”
BackgroundRedoxisome and diabetic retinopathy: Pathophysiology and therapeutic interventions
Sharma, I., Yadav, K. S., & Mugale, M. N. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106292 · Cited by 50
Tirado, Ò. M., MacCarthy, C. M., Fatima, N., Villar, J., Mateo‐Lozano, S., & Notario, A. V. (2009) · International Journal of Cancer · doi:10.1002/ijc.24754 · Cited by 49
Analysis of Induced Pluripotent Stem Cells from a BRCA1 Mutant Family
Soyombo, A. A., Wu, Y., Kolski, L., Rios, J. J., Rakheja, D., Chen, A. P., Kehler, J., Hampel, H., Coughran, A. J., & Ross, T. S. (2013) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.08.004 · Cited by 49
PKCλ/ι signaling promotes triple-negative breast cancer growth and metastasis
Paul, A., Gunewardena, S., Stecklein, S. R., Saha, B., Parelkar, N. K., Danley, M., Rajendran, G., Home, P., Ray, S. S., Jokar, I., et al. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.62 · Cited by 48
“The PKC family consists of multiple serine/threonine kinases and the relative contribution of individual PKC isoforms during cancer progression varies due to pleiotropism.(12) PKC isoforms regulate diverse cellular functions such as cell-cycle”
BackgroundKim, M.-J., Kim, R.-K., Yoon, C., An, S., Hwang, S., Suh, Y., Park, M. J., Chung, H. Y., Kim, I. G., & Lee, S. (2011) · Journal of Cell Science · doi:10.1242/jcs.080119 · Cited by 53
“Members of the protein kinase C (PKC) family of serine/ threonine kinases are key components of signal transduction pathways that regulate proliferation, cell survival and malignant transformation (Griner and Kazanietz, 2007; Parekh et al., 2000; Steinberg, 2004).”
BackgroundInfluentialModular Total Synthesis of Protein Kinase C Activator (−)-Indolactam V
Haynes-Smith, J., Diaz, I., & Billingsley, K. L. (2016) · Organic Letters · doi:10.1021/acs.orglett.6b00614 · Cited by 48
Surface-Transfer Mass Spectrometry Imaging of Renal Tissue on Gold Nanoparticle Enhanced Target
Nizioł, J., Ossoliński, K., Ossoliński, T., Ossolińska, A., Bonifay, V., Sekuła, J., Dobrowolski, Z. F., Sunner, J. A., Beech, I. B., & Ruman, T. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b01859 · Cited by 48
Protein Kinases C-Mediated Regulations of Drug Transporter Activity, Localization and Expression
Mayati, A., Moreau, A., Vée, M. L., Stieger, B., Denizot, C., Parmentier, Y., & Fardel, O. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040764 · Cited by 55
AKR1B10 activates diacylglycerol (DAG) second messenger in breast cancer cells
Huang, C., Cao, Z., Ma, J., Shen, Y., Bu, Y., Khoshaba, R., Shi, G., Huang, D. A., Liao, D., Ji, H., et al. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22844 · Cited by 48
“Hydrolysis by PLC, PIP2 is broken down into DAG and IP3.”
BackgroundInfluentialGharib, E., Nasrabadi, P. N., & Zali, M. R. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29488 · Cited by 48
“…and phosphatidylinositol (3,4,5)‐trisphosphate are derived from membrane phospholipids in response to extracellular stimuli and activate various intracellular‐ signaling cascades involved in cell proliferation and survival (Griner & Kazanietz, 2007; Vanhaesebroeck, Stephens, & Hawkins, 2012).”
BackgroundActive Site Inhibitors Protect Protein Kinase C from Dephosphorylation and Stabilize Its Mature Form
Gould, C. M., Antal, C. E., Reyes, G. X., Kunkel, M. T., Adams, R. A., Ziyar, A., Riveros, T., & Newton, A. C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.272526 · Cited by 53
Effects of Jatropha curcas oil in Lactuca sativa root tip bioassays
Vieira, L. F. A., Botelho, C. M., Laviola, B. G., Palmieri, M. J., & Fontes, M. M. P. (2014) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201420130041 · Cited by 47
Cone, A. C., Cavin-Meza, G., Ambrosi, C., Hakozaki, H., Wu-Zhang, A. X., Kunkel, M. T., Newton, A. C., & Sosinsky, G. E. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.533265 · Cited by 47
Huang, W., Bansode, R. R., Bal, N. C., Mehta, M., & Mehta, K. D. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m019687 · Cited by 48
Ziemba, B. P., Li, J., Landgraf, K. E., Knight, J. D., Voth, G. A., & Falke, J. J. (2014) · Biochemistry · doi:10.1021/bi4016082 · Cited by 50
Villar, J., Arenas, M. I., MacCarthy, C. M., Blánquez, M. J., Tirado, Ò. M., & Notario, V. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2041 · Cited by 55
Impaired respiratory burst contributes to infections in PKCδ-deficient patients
Neehus, A., Moriya, K., Nieto-Patlán, A., Voyer, T. L., Lévy, R., Özen, A., Karakoç-Aydıner, E., Barış, S., Yıldıran, A., Altundağ, E., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20210501 · Cited by 50
Caino, M. C., von Burstin, V. A., López‐Haber, C., & Kazanietz, M. G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.194332 · Cited by 47
Self-citationProtein Kinase C-ε Promotes EMT in Breast Cancer
Jain, K., & Basu, A. (2014) · Breast Cancer Basic and Clinical Research · doi:10.4137/bcbcr.s13640 · Cited by 51
Liu, J., Cheng, H., He, D., He, X., Wang, K., Liu, Q., Zhao, S., & Yang, X. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b01739 · Cited by 46
Cytosolic Ca2+ Modulates Golgi Structure Through PKCα-Mediated GRASP55 Phosphorylation
Ireland, S., Ramnarayanan, S., Fu, M., Zhang, X., Zhang, J., Li, J., Emebo, D., & Wang, Y. (2020) · iScience · doi:10.1016/j.isci.2020.100952 · Cited by 50
Irie, K., & Yanagita, R. C. (2014) · The Chemical Record · doi:10.1002/tcr.201300036 · Cited by 48
p23/Tmp21 Associates with Protein Kinase Cδ (PKCδ) and Modulates Its Apoptotic Function
Wang, H., Xiao, L., & Kazanietz, M. G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.227991 · Cited by 46
Self-citationvon Burstin, V. A., Xiao, L., & Kazanietz, M. G. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.064741 · Cited by 50
“On the other hand, PKC generally activates survival and mitogenic pathways in normal and cancer cells (Reyland et al., 1999; Blass et al., 2002; Basu and Sivaprasad, 2007; Griner and Kazanietz, 2007).”
BackgroundSelf-citationBenhadji, K. A., Serova, M., Ghoul, A., Cvitkovic, E., Tourneau, C. L., Ogbourne, S. M., Lokiec, F. M., Calvo, F. M., Hammel, P. R., Faivre, S. J., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604642 · Cited by 46
“The expression of PKC isozymes in tumours has been shown to be partially tissue specific (Pongracz et al, 1995; Verstovsek et al, 1998; Griner and Kazanietz, 2007).”
BackgroundBayet‐Robert, M., Morvan, D., Chollet, P. J. M., & Barthomeuf, C. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0430-1 · Cited by 45
“In contrast to PKCe, high levels of activated PKCd were associated with sensitivity to DTX and proapoptotic response through JNK activation [ 38 ].”
BackgroundRuvolo, P. P., Zhou, L., Watt, J. C., Ruvolo, V. R., Burks, J. K., Jiffar, T., Kornblau, S. M., Konopleva, M. Y., & Andreeff, M. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23090 · Cited by 45
Apoptotic Phosphorylation of Histone H3 on Ser-10 by Protein Kinase Cδ
Park, C.-H., & Kim, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044307 · Cited by 45
“Protein kinase C (PKC), a family of serine/threonine protein kinases, is activated by various stimuli and involved in cellular processes, such as proliferation, survival, differentiation, and apoptosis [13,14].”
BackgroundProtein kinase C beta II suppresses colorectal cancer by regulating IGF-1 mediated cell survival
Dowling, C. M., Phelan, J. J., Callender, J. A., Cathcart, M. C., Mehigan, B. J., McCormick, P. H., Dalton, T. M., Coffey, J. C., Newton, A. C., O'Sullivan, J. N., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8062 · Cited by 53
“Research into the role of different PKC isoforms in cancer is based primarily on the assumption that increased PKC activation and expression promotes carcinogen induced tumorigenesis [1–3, 19, 20].”
Oxidative Stress and ROS Link Diabetes and Cancer
Black, H. S. (2024) · Journal of Molecular Pathology · doi:10.3390/jmp5010007 · Cited by 50
“…PKC isozymes that Ca 2+ as a cofactor; non-classic, regulated by DAG with no that is The most widely studied isozymes, in relation to cancer, have been PKC α , β , ε , and δ [134]. widely studied isozymes, in relation to [11,136], bladder [137], colon [138], gastric [ not activated by DAG [135].”
BackgroundMeshki, J., Caino, M. C., von Burstin, V. A., Griner, E., & Kazanietz, M. G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.128371 · Cited by 44
Self-citationCompensatory mechanisms in genetic models of neurodegeneration: are the mice better than humans?
Kreiner, G. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00056 · Cited by 48
“…TrkB tyrosine kinase receptor (mainly activated by BDNF) have revealed a profound loss of dopaminergic neurons in the region of the substantia nigra (SN) together with elevated levels of dopamine in the striatum and yet no alteration in the turnover of this neurotransmitter (Zaman et al., 2004).”
BackgroundUnbalanced Immune System: Immunodeficiencies and Autoimmunity
Giardino, G., Gallo, V., Prencipe, R., Gaudino, G., Romano, R., CATALDIS, M. D., Lorello, P., Palamaro, L., Giacomo, C. D., Capalbo, D., et al. (2016) · Frontiers in Pediatrics · doi:10.3389/fped.2016.00107 · Cited by 47
“PRKCD plays a key role in the regulation of cell survival, proliferation, and apoptosis (44).”
BackgroundRamli, N. Z., Yahaya, M. F., Tooyama, I., & Damanhuri, H. A. (2020) · Antioxidants · doi:10.3390/antiox9101019 · Cited by 48
Protein kinase C fusion proteins are paradoxically loss of function in cancer
Van, A. N., Kunkel, M. T., Baffi, T. R., Lordén, G., Antal, C. E., Banerjee, S., & Newton, A. C. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100445 · Cited by 45
Monteleone, L., Speciale, A., Valenti, G. E., Traverso, N., Ravera, S., Garbarino, O., Leardi, R., Farinini, E., Roveri, A., Ursini, F., et al. (2021) · Antioxidants · doi:10.3390/antiox10050691 · Cited by 47
“PKCα activation has been implicated in promoting cancer progression [18,77] and in the formation and survival of cancer stem cells [78] Moreover, it has been demonstrated that the pharmacologic inhibition of PKCα can target breast CSCs [78] and override ZEB1-induced chemoresistance in hepatocarcinoma [79].”
BackgroundCharacterizing the breast cancer lipidome and its interaction with the tissue microbiota
Giallourou, N., Urbaniak, C., Puebla-Barragan, S., Vorkas, P. A., Swann, J. R., & Reid, G. (2021) · Communications Biology · doi:10.1038/s42003-021-02710-0 · Cited by 46
Protein kinase D2 regulates migration and invasion of U87MG glioblastoma cells in vitro
Bernhart, E. M., Damm, S., Wintersperger, A., DeVaney, T. T. J., Zimmer, A., Raynham, T. M., Ireson, C. R., & Sattler, W. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.03.029 · Cited by 44
Egidy, G., Julé, S., Bossé, P., Bernex, F., Geffrotin, C., Vincent-Naulleau, S. S., Horák, V., Sastre‐Garau, X., & Panthier, J. (2008) · Molecular Cancer · doi:10.1186/1476-4598-7-34 · Cited by 44
“PKC, the main target of TPA, has important roles in cell-cycle regulation, cell survival, malignant transformation and apoptosis [34].”
BackgroundAFM as a tool to probe and manipulate cellular processes
Lamontagne, C., Cuerrier, C. M., & Grandbois, M. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-007-0414-0 · Cited by 44
“Deregulation of PKC is an important feature in the invasiveness and metastatic behaviour of cancer cells [68].”
BackgroundMaksoud, A. I. A. E., Taher, R. F., Gaara, A. H., Abdelrazik, E., Keshk, O. S., Elawdan, K. A., Morsy, S. E., Salah, A., & Khalil, H. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01220 · Cited by 43
“Double delta Ct analysis was used to drive the expression fold change of mRNA detected by qRT-PCR using the following equation: (1) 1Ct = Ct value for gene- Ct value for GAPDH, (2) (11Ct) = 1Ct for value (experimental) –1Ct for value (control), (3) Expression fold change= (2−11ct) (28).”
MethodCaino, M. C., López‐Haber, C., Kim, J., Mochly‐Rosen, D., & Kazanietz, M. G. (2011) · Oncogene · doi:10.1038/onc.2011.428 · Cited by 43
“PKCe depletion impairs anchorage-dependent and anchorage-independent NSCLC cell growth Overexpression of PKCe, a member of the novel PKC family, is a hallmark of human epithelial cancers particularly in NSCLC tumors (Bae et al., 2007; Griner and Kazanietz, 2007).”
Self-citationWildburger, N. C., Wood, P. L., Gumin, J., Lichti, C. F., Emmett, M. R., Lang, F. F., & Nilsson, C. L. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00076 · Cited by 44
“A significant decrease in DHA and DHAcontaining glycerophospholipids has been previously observed in malignant glioma compared to normal brain tissue (57-58).”
BackgroundZheng, J., Kong, C., Yang, X., Cui, X., Lin, X., & Zhang, Z. (2017) · BMC Cancer · doi:10.1186/s12885-017-3401-7 · Cited by 44
Novel phosphorylation site markers of protein kinase C delta activation
Durgan, J., Michael, N., Totty, N., & Parker, P. J. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.06.035 · Cited by 40
“Significantly, a growing body of work indicates that PKCd acts as a tumour suppressor, presumably through its well-documented growth inhibitory and/or pro-apoptotic activities (reviewed in [13]).”
BackgroundVillar, J., Quadri, H. S., Song, I., Tomita, Y. A., Tirado, Ò. M., & Notario, V. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2922 · Cited by 43
“Most of what is known on the role of individual PKC isoforms in the regulation of apoptosis in human PCa cells derives from mechanistic studies about the cell death–inducing activity of phorbol esters, a group of carcinogenesis promoters and wellcharacterized PKC activators (31, 42).”
Background
Metadata
- Authors
- Griner, E. M., & Kazanietz, M. G.
- Affiliations
- University of Pennsylvania (US)
- Corresponding author
- Kazanietz, Marcelo G.
- Venue
- Nature Reviews Cancer
- Published
- 2007-04
- Volume
- 7
- Issue
- 4
- Pages
- 281-294
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1987496015
- Cited by
- 978
- References
- 190
- Citations by year
- 2026: 11 · 2025: 25 · 2024: 16 · 2023: 28 · 2022: 32 · 2021: 35 · 2020: 47 · 2019: 35 · 2018: 46 · 2017: 56 · 2016: 55 · 2015: 44 · 2014: 80 · 2013: 66 · 2012: 71
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- protein kinase C, diacylglycerol, phorbol ester, tumor promotion, carcinogenesis, tumor progression, cell cycle regulation, apoptosis, malignant transformation, cell survival, small GTPases, signal transduction
- MeSH terms
- Cell Cycle, Diglycerides, Enzyme Activation, Humans, Isoenzymes, Neoplasms, Neovascularization, Pathologic, Peptide Hydrolases, Phorbol Esters, Protein Kinase C, Apoptosis, GTP Phosphohydrolases, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.